Paper29655835
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
Kirchgesner J and 5 others. Gastroenterology, 2018. Cited by 485 papers, by iCite.
Cite this record
ConductScience Library. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Papers, record 29655835. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29655835
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppressive Agents | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Opportunistic Infections | Major topic |
| Adult | |
| Drug Therapy, Combination | |
| Female | |
| Follow-Up Studies | |
| France | |
| Humans | |
| Male | |
| Middle Aged | |
| Proportional Hazards Models | |
| Risk Assessment | |
| Severity of Illness Index | |
| Young Adult |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29966613 | Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies. | https://conductscience.org/library/papers/29966613 |
Source PubMed
Cited by282
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 485 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928005 | [KASID Guidelines for the Medical Treatment of Crohn's Disease: 2026]. | Korean J Gastroenterol | 2026 | https://conductscience.org/library/papers/42928005 | PubMed |
| 42803770 | Cloud-Based and Locally Deployed Language Models in Nursing and Health Care: An AI Act-Aligned Framework. | JMIR Med Inform | 2026 | https://conductscience.org/library/papers/42803770 | PubMed |
| 42536534 | A systematic review and meta-analysis of acupuncture for intestinal protection and underlying mechanisms in animal models of ulcerative colitis. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42536534 | PubMed |
| 42503158 | Successful transition to mirikizumab following hepatic abscess during adalimumab therapy in a patient with ulcerative colitis. | Clin J Gastroenterol | 2026 | https://conductscience.org/library/papers/42503158 | PubMed |
| 42465743 | Engineered Escherichia coli Nissle 1917 secreting anti-TNF-α nanobody as a single-strain live biotherapeutic for inflammatory bowel disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465743 | PubMed |
| 42336275 | Protection or Vulnerability? The Context-Dependent Memory of Intestinal Inflammation. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42336275 | PubMed |
| 42334197 | Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study. | Inflamm Bowel Dis | 2026 | https://conductscience.org/library/papers/42334197 | PubMed |
| 42220316 | Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis. | Elife | 2026 | https://conductscience.org/library/papers/42220316 | PubMed |
| 42209193 | From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventions. | Gut | 2026 | https://conductscience.org/library/papers/42209193 | PubMed |
| 42195197 | Ear, Nose, and Throat Manifestations in Inflammatory Bowel Diseases: A Systematic Review of the Clinical Spectrum. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42195197 | PubMed |
| 42059639 | Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment. | Infect Immun | 2026 | https://conductscience.org/library/papers/42059639 | PubMed |
| 42045813 | Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patients. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42045813 | PubMed |
| 42027412 | Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person care. | Crohns Colitis 360 | 2026 | https://conductscience.org/library/papers/42027412 | PubMed |
| 42026959 | [Advanced Combination Therapy in Inflammatory Bowel Disease]. | Korean J Gastroenterol | 2026 | https://conductscience.org/library/papers/42026959 | PubMed |
| 41976865 | Adverse Events in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Nationwide, Population-Based, Propensity-Matched Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41976865 | PubMed |
| 41949596 | Tofacitinib safety in inflammatory bowel disease: a disproportionality analysis of the FDA adverse event reporting system. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41949596 | PubMed |
| 41930211 | Analysis of the use of monoclonal antibodies in the treatment of Crohn's disease. | Antib Ther | 2026 | https://conductscience.org/library/papers/41930211 | PubMed |
| 41869355 | Case report: Tumor-like mediastinal tuberculous lymphadenitis with paravertebral cold abscess under cumulative immunosuppression: a case highlighting altered host-pathogen interactions. | Front Immunol | 2026 | https://conductscience.org/library/papers/41869355 | PubMed |
| 41828431 | Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828431 | PubMed |
| 41821816 | Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges. | Front Gastroenterol (Lausanne) | 2023 | https://conductscience.org/library/papers/41821816 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29655835
GET https://conductscience.org/api/papers/v1/29655835/cited_by?page=2